Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,186 | -4,595 | -15,665 | -16,286 | -448 |
| Depreciation Amortization | 699 | 4,687 | 4,101 | 2,766 | 1,384 |
| Income taxes - deferred | 9 | 65 | 65 | 51 | 6 |
| Accounts receivable | -5,104 | 264 | -1,674 | -892 | 1 |
| Accounts payable and accrued liabilities | 2,206 | -2,086 | -1,134 | -455 | -828 |
| Other Working Capital | -6,881 | -8,909 | -6,666 | -3,677 | -3,762 |
| Other Operating Activity | 7,394 | 30,689 | 36,172 | 27,588 | 5,374 |
| Operating Cash Flow | $-491 | $20,115 | $15,199 | $9,095 | $1,727 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -167 | -9,478 | -5,220 | -1,918 | -175 |
| Net Acquisitions | N/A | 23,516 | N/A | N/A | N/A |
| Purchase Of Investment | -20,430 | -114,063 | -79,393 | -64,303 | -30,324 |
| Sale Of Investment | 18,767 | 41,593 | 22,943 | 10,145 | 3,573 |
| Other Investing Activity | 0 | -13,107 | -11,006 | -10,633 | -250 |
| Investing Cash Flow | $-1,830 | $-71,539 | $-72,676 | $-66,709 | $-27,176 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2,500 | -10,000 | -7,500 | -5,000 | -2,500 |
| Common Stock Issued | 190 | 18 | 18 | 18 | 0 |
| Other Financing Activity | -5,585 | -942 | -946 | -888 | -492 |
| Financing Cash Flow | $-7,895 | $-10,924 | $-8,428 | $-5,870 | $-2,992 |
| Beginning Cash Position | 33,038 | 95,386 | 95,386 | 95,386 | 95,386 |
| End Cash Position | 22,822 | 33,038 | 29,481 | 31,902 | 66,945 |
| Net Cash Flow | $-10,216 | $-62,348 | $-65,905 | $-63,484 | $-28,441 |
| Free Cash Flow | |||||
| Operating Cash Flow | -491 | 20,115 | 15,199 | 9,095 | 1,727 |
| Capital Expenditure | -167 | -9,478 | -5,220 | -1,918 | -175 |
| Free Cash Flow | -658 | 10,637 | 9,979 | 7,177 | 1,552 |